Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)

SHE:002755 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	1,189	1,422	1,411	1,047	772.71	1,166
Trading Asset Securities	1,147	1,059	683.28	713.83	839.08	522.39
Cash & Short-Term Investments	2,335	2,481	2,095	1,761	1,612	1,688
Cash Growth	-1.55%	18.43%	18.96%	9.25%	-4.51%	14.90%
Accounts Receivable	262.76	279.17	231.83	181.24	323.03	581.86
Other Receivables	4.63	6.77	13.02	49.88	25.21	16.29
Receivables	267.39	285.94	244.85	231.12	348.23	598.15
Inventory	121.39	124.55	196.99	167.49	141.53	141.84
Other Current Assets	40.99	99.24	31.59	27	36.56	59.14
Total Current Assets	2,765	2,991	2,568	2,186	2,138	2,487
Property, Plant & Equipment	387.05	415.06	474.03	478.4	547.14	658.33
Long-Term Investments	45.7	47.61	118.72	118.21	107.57	105.18
Other Intangible Assets	556.61	578.89	146.34	98.34	95.77	97.69
Long-Term Deferred Tax Assets	38.96	24.65	24.62	25.73	25.85	28.69
Long-Term Deferred Charges	560.2	423.1	676.78	563.46	453.7	342.02
Other Long-Term Assets	34.97	37.26	38.97	53.26	46.22	5.75
Total Assets	4,389	4,517	4,048	3,524	3,414	3,725

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	49.07	121.07	59.98	38.29	39.08	65.72
Accrued Expenses	16.51	34	40.84	43.6	119.56	133.48
Short-Term Debt	-	27	62	114.02	45.03	-
Current Portion of Leases	2.55	2.79	4.06	3.03	3.45	2.61
Current Income Taxes Payable	18.03	34.18	2.05	3.59	2.13	7.54
Current Unearned Revenue	232.91	283.61	108.51	15.88	11.68	15.26
Other Current Liabilities	687.96	664.17	543.53	213.14	102.81	177.11
Total Current Liabilities	1,007	1,167	820.96	431.55	323.74	401.71
Long-Term Leases	3.82	4.04	6.62	6.75	8.92	11.52
Long-Term Unearned Revenue	65.96	56.1	60.66	64.72	55.81	68.93
Long-Term Deferred Tax Liabilities	16.16	16.01	17.15	10.18	12.56	15.08
Total Liabilities	1,093	1,243	905.39	513.2	401.03	497.24

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	928.16	928.16	928.16	928.16	928.16	928.16
Additional Paid-In Capital	163.64	163.64	136.94	136.94	50.73	0.94
Retained Earnings	2,123	2,114	1,989	1,828	1,977	2,295
Comprehensive Income & Other	9.8	9.78	8.95	6.58	7.25	-5.9
Total Common Equity	3,225	3,215	3,063	2,900	2,963	3,219
Minority Interest	70.97	58.71	79.59	110.7	50.37	8.82
Shareholders' Equity	3,296	3,274	3,142	3,011	3,013	3,228
Total Liabilities & Equity	4,389	4,517	4,048	3,524	3,414	3,725

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	6.37	33.83	72.67	123.8	57.41	14.13
Net Cash (Debt)	2,329	2,447	2,022	1,637	1,554	1,674
Net Cash Growth	0.52%	21.01%	23.52%	5.32%	-7.14%	15.51%
Net Cash Per Share	2.48	2.59	2.14	1.76	1.65	1.81
Filing Date Shares Outstanding	928.16	928.16	928.16	928.16	928.16	928.16
Total Common Shares Outstanding	928.16	928.16	928.16	928.16	928.16	928.16
Working Capital	1,758	1,824	1,747	1,755	1,814	2,085
Book Value Per Share	3.47	3.46	3.30	3.12	3.19	3.47
Tangible Book Value	2,668	2,637	2,916	2,802	2,867	3,121
Tangible Book Value Per Share	2.87	2.84	3.14	3.02	3.09	3.36
Buildings	381.29	385.99	385.96	375.5	371.29	437.94
Machinery	778.54	803.98	804.36	744.21	767.2	776.51
Construction In Progress	32.04	29.85	23.51	36.07	29.8	19.71

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error